ABL Europe

ABL is a pure contract development and manufacturing organization (CDMO), specializing in the development and manufacturing of vaccine candidate viruses, gene therapies, and cancer treatments. ABL's mission is to provide GMP viral vectors from development to market, contributing to the success of customers' immunotherapy innovations. ABL's CDMO services include active pharmaceutical ingredients, drug product filling/finished products, process and analytical development, as well as bioanalytical testing.